In yesterday’s Wall Street session, Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares traded at $0.11, up 6.50% from the previous session.
CDT stock price is now -26.47% away from the 50-day moving average and -94.89% away from the 200-day moving average. The market capitalization of the company currently stands at $10.22M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In other news, Nirland Ltd, 10% Owner sold 1,500,000 shares of the company’s stock on Oct 03 ’24. The stock was sold for $156,450 at an average price of $0.10. Upon completion of the transaction, the 10% Owner now directly owns 8,400,000 shares in the company, valued at $0.92 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 04 ’24, 10% Owner Nirland Ltd sold 1,368,991 shares of the business’s stock. A total of $140,458 was realized by selling the stock at an average price of $0.10. This leaves the insider owning 7,031,009 shares of the company worth $0.77 million. A total of 56.57% of the company’s stock is owned by insiders.
During the past 12 months, Conduit Pharmaceuticals Inc has had a low of $0.09 and a high of $7.83. The fifty day moving average price for CDT is $0.14492 and a two-hundred day moving average price translates $2.083635 for the stock.
The latest earnings results from Conduit Pharmaceuticals Inc (NASDAQ: CDT) was released for 2024-06-30. The company reported revenue of $3.14 million for the quarter, compared to $1.31 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 138.78 percent.
